DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Wick A, Dörner N, Schäfer N. , et al.
Bevacizumab does not increase the risk of remote relapse in malignant glioma.
Ann Neurol 2011;
69 (03) 586-592
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.